No Data
No Data
Capricor Stock Rallies 20% on DMD Data Presentation Update
National Bank on DRI Healthcare's Casgevy Stream Acquisition
Vertex Pharmaceuticals Is Maintained at Sector Perform by RBC Capital
Express News | RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Lowers Price Target to $425
Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Vertex Pharmaceuticals (VRTX) and Edwards Lifesciences (EW)
DBS Initiates Vertex Pharmaceuticals(VRTX.US) With Hold Rating